#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1009855	F	Antiviral activity against ganciclovir-resistant HCMV AD169 clone 4 infected in HEL cells assessed as inhibition of virus-induced cytopathicity	Human betaherpesvirus 5	7		organism-based format	Scientific Literature
2.	ALA1012626	F	Antiviral activity against Reovirus 3 infected in african green monkey Vero cells	Mammalian orthoreovirus 3	4		organism-based format	Scientific Literature
3.	ALA1012627	F	Antiviral activity against Sindbis virus infected in african green monkey Vero cells	Sindbis virus	4		organism-based format	Scientific Literature
4.	ALA1012628	F	Antiviral activity against Coxsackievirus B4 infected in african green monkey Vero cells	Coxsackievirus B4	4		organism-based format	Scientific Literature
5.	ALA1012629	F	Antiviral activity against VSV infected in human HeLa cells	Vesicular stomatitis virus	4		organism-based format	Scientific Literature
6.	ALA1012630	F	Antiviral activity against HSV1 KOS infected in human HEL cells	Human alphaherpesvirus 1	4		organism-based format	Scientific Literature
7.	ALA1012631	F	Antiviral activity against Coxsackievirus B4 infected in human HeLa cells	Coxsackievirus B4	4		organism-based format	Scientific Literature
8.	ALA1012632	F	Antiviral activity against RSV infected in human HeLa cells	Respiratory syncytial virus	4		organism-based format	Scientific Literature
9.	ALA1012633	F	Antiviral activity against acyclovir-resistant thymine kinase-deficient HSV1 infected in human HEL cells	Human alphaherpesvirus 1	4		organism-based format	Scientific Literature
10.	ALA1012634	F	Antiviral activity against HSV2 infected in human HEL cells	Human alphaherpesvirus 2	4		organism-based format	Scientific Literature
11.	ALA1012635	F	Antiviral activity against Vaccinia virus infected in human HEL cells	Vaccinia virus	4		organism-based format	Scientific Literature
12.	ALA1012636	F	Antiviral activity against VSV infected in human HEL cells	Vesicular stomatitis virus	4		organism-based format	Scientific Literature
13.	ALA1012637	F	Antiviral activity against HCMV Davis infected in human HEL cells assessed inhibition of virus-induced cytopathicity after 7 days postinfection	Human betaherpesvirus 5	37		organism-based format	Scientific Literature
14.	ALA1012638	F	Antiviral activity against HCMV AD169 infected in human HEL cells assessed inhibition of virus-induced cytopathicity after 7 days postinfection	Human betaherpesvirus 5	37		organism-based format	Scientific Literature
15.	ALA1012639	F	Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation	Human alphaherpesvirus 3	37		organism-based format	Scientific Literature
16.	ALA1012640	F	Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation	Human alphaherpesvirus 3	37		organism-based format	Scientific Literature
17.	ALA1012641	A	Cytotoxicity against human HEL cells assessed as morphological alteration after 3 days	Homo sapiens	39		cell-based format	Scientific Literature
18.	ALA1012642	A	Cytotoxicity against human HEL cells assessed as reduction of growth after 3 days	Homo sapiens	39		cell-based format	Scientific Literature
19.	ALA1012643	F	Antiviral activity against Varicella zoster virus YS infected in human HEL cells assessed reduction in viral plaque formation	Human alphaherpesvirus 3	4		organism-based format	Scientific Literature
20.	ALA1013491	F	Antiviral activity against foscarnet-resistant HCMV AD169 clone C infected in HEL cells assessed as inhibition of virus-induced cytopathicity	Human betaherpesvirus 5	7		organism-based format	Scientific Literature